Freenome, Inc. (FRNM)
NASDAQ: FRNM · Real-Time Price · USD
10.15
+0.09 (0.89%)
Jul 30, 2026, 2:11 PM EDT - Market open
Freenome Employees
Freenome had 363 employees as of March 31, 2026. The number of employees did not change since the number was last reported on December 31, 2025.
Employees
363
Change
n/a
Growth
n/a
Revenue / Employee
$94,317
Profits / Employee
-$619,912
Market Cap
1.15B
Employees Chart
| Date | Employees | Change (1Y) | Growth (1Y) | Full-Time | Part-Time |
|---|---|---|---|---|---|
| Mar 31, 2026 | 363 | 0 | - | 363 | 0 |
| Dec 31, 2025 | 363 | 5 | 1.40% | 363 | 0 |
| Dec 31, 2024 | 358 | - | - | 353 | 5 |
Related Stocks
| Company Name | Employees |
|---|---|
| Myriad Genetics | 2,700 |
| NeoGenomics | 2,500 |
| OPKO Health | 2,275 |
| Fulgent Genetics | 1,315 |
| GeneDx Holdings | 1,300 |
| Castle Biosciences | 942 |
| GRAIL | 910 |
| CareDx | 765 |
FRNM News
- 3 days ago - FDA approves Freenome's blood test for colorectal cancer screening - Reuters
- 3 days ago - FDA Approves Freenome's SimpleScreen™ CRC Blood-Based Screening Test; Abbott to Commercialize in the U.S. - GlobeNewsWire
- 9 days ago - Freenome Debuts as a Publicly Traded Company Focused on Blood-Based Early Cancer Detection - GlobeNewsWire